Tag: iShares NASDAQ Biotechnology ETF

Waning Upside Momentum Forewarn Lower Stocks Prices

daily chart of the S&P has shown significant signs that momentum is waning, suggesting that the index vulnerable to some downside retracement over the short-to-intermediate term. If S&P fails to hold above 2995, then the next stop will be 2960 with the possibility of a brief breakdown below that level

S&P in Orderly High Level Consolidation Phase

recent trading actions leaving the S&P in what looks to us like an orderly high level consolidation of the March rally. The index is ticking ever closer to 2900, a level it has not breached since market broke down in late 2018. Some aggressive traders might use this level like a magnet to sell against, but it doesn’t have much significance outside of just being a nice round number

Trading Strategy – iShares Nasdaq Biotechnology ETF

  One of the more noteworthy developments in recent days has been the move in biotech stocks.  The group attracted strong buying support in recent day that saw the iShares Nasdaq Biotechnology ETF (IBB) surged more than 4 percent last week, bringing its YTD gains up to 14.4 percent while the S&P gained 8.5 percent […]

Trading Strategy – iShares Nasdaq Biotechnology ETF

  Biotech caught a bid Friday after Biogen announced positive results from a study on a drug aimed at treating early Alzheimer’s disease, its shares rose nearly 20 percent.  The iShares Nasdaq Biotechnology ETF (IBB) surged 3.8 percent, bringing its YTD gains up to nearly 9 percent, outperformed the S&P by a wide margin.  Now […]

Next Page »